Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Cognitive impairment affects the majority of people living with schizophrenia and remains an area where no therapy has yet been approved, said Chris Kroeger, cofounder and CEO of MapLight in the statement
We supply this compound exclusively for in vitro laboratory research and analytical applications
NAD+ is received via an injection either in our office or you can do them yourself in your home.
Strength Available
US$ 27.31
US$ 20.77
US$ 26.40
US$ 29.46
US$ 28.00
